Literature DB >> 10837170

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.

J J Carter1, L A Koutsky, J P Hughes, S K Lee, J Kuypers, N Kiviat, D A Galloway.   

Abstract

The relationship between human papillomavirus (HPV) DNA in the genital mucosa and serum IgG to HPV-16, -18, and -6 was studied in a cohort of 588 college women. Among women with incident HPV infections, 59.5%, 54.1%, and 68.8% seroconverted for HPV-16, -18, or -6, respectively, within 18 months of detecting the corresponding HPV DNA. Transient HPV DNA was associated with a failure to seroconvert following incident HPV infection; however, some women with persistent HPV DNA never seroconverted. Antibody responses to each type were heterogeneous, but several type-specific differences were found: seroconversion for HPV-16 occurred most frequently between 6 and 12 months of DNA detection, but seroconversion for HPV-6 coincided with DNA detection. Additionally, antibody responses to HPV-16 and -18 were significantly more likely to persist during follow-up than were antibodies to HPV-6.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837170     DOI: 10.1086/315498

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  165 in total

1.  Detection of HPV types and neutralizing antibodies in women with genital warts in Tianjin City, China.

Authors:  Xue-ling Wu; Chun-tao Zhang; Xiao-ke Zhu; You-chun Wang
Journal:  Virol Sin       Date:  2010-02-12       Impact factor: 4.327

Review 2.  Human papillomavirus in head and neck tumors: epidemiological, molecular and clinical aspects.

Authors:  Jan Klozar; Ruth Tachezy; Eliška Rotnáglová; Eva Košlabová; Martina Saláková; Eva Hamšíková
Journal:  Wien Med Wochenschr       Date:  2010-06

3.  Review of Gardasil.

Authors:  Diane M Harper; Stephen L Vierthaler; Jennifer A Santee
Journal:  J Vaccines Vaccin       Date:  2010-11-23

Review 4.  Vaccinations for Anal Squamous Cancer: Current and Emerging Therapies.

Authors:  John Berry; Sean C Glasgow
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

Review 5.  Prophylactic HPV vaccines.

Authors:  Margaret Stanley
Journal:  J Clin Pathol       Date:  2007-01-26       Impact factor: 3.411

6.  Genital human papillomavirus (HPV) concordance in heterosexual couples.

Authors:  Alan G Nyitray; Lynette Menezes; Beibei Lu; Hui-Yi Lin; Dan'elle Smith; Martha Abrahamsen; Mary Papenfuss; Christine Gage; Anna R Giuliano
Journal:  J Infect Dis       Date:  2012-04-26       Impact factor: 5.226

7.  Human papillomaviruses: a growing field.

Authors:  Denise A Galloway
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

8.  Difficulties in estimating the male-to-female sexual transmissibility of human papillomavirus infection.

Authors:  Ali Rowhani-Rahbar; James P Hughes; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2009-04       Impact factor: 2.830

Review 9.  Immune therapy for human papillomaviruses-related cancers.

Authors:  Ricardo Rosales; Carlos Rosales
Journal:  World J Clin Oncol       Date:  2014-12-10

10.  Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study.

Authors:  Lauren E Wilson; Michael Pawlita; Phillip E Castle; Tim Waterboer; Vikrant Sahasrabuddhe; Patti E Gravitt; Mark Schiffman; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2013-05-29       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.